Octagon Capital Advisors LP Cytek Biosciences, Inc. Call Options Transaction History
Octagon Capital Advisors LP
- $433 Million
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CTKB
# of Institutions
133Shares Held
73.8MCall Options Held
200Put Options Held
100-
Black Rock Inc. New York, NY17.1MShares$83.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$57.6 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD11.4MShares$55.8 Million1.3% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$32.6 Million0.96% of portfolio
-
State Street Corp Boston, MA3.97MShares$19.5 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $660M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...